Abstract Details

Title Analysis of Predictive Biomarkers for Estimation of MS Patients' Long-Term IFN-[beta] Therapy Outcome

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 001

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Brigitte Paap (University of Rostock)	No disclosure on file
Ronald M. Lazar, PhD, FAHA, F�鶹��ýӳ�� (University of Alabama At Birmingham)	Dr. Lazar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DiaMedica Therapeutics Inc. . The institution of Dr. Lazar has received research support from National Institutes of Health. Dr. Lazar has received publishing royalties from a publication relating to health care.
Michael Hecker, PhD (Universitatsmedizin Rostock, Klinik Fur Neurologie)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file